awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q48194472-4B47C033-F450-464C-93AA-0E40791B9C19
Q48194472-4B47C033-F450-464C-93AA-0E40791B9C19
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48194472-4B47C033-F450-464C-93AA-0E40791B9C19
PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival.
P2860
Q48194472-4B47C033-F450-464C-93AA-0E40791B9C19
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48194472-4B47C033-F450-464C-93AA-0E40791B9C19
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
39083a6afc324a6ae9f8c85275df9e327b23a19c
P2860
PSMA-Based Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer: The Bad Berka Experience Since 2013.